期刊文献+

Clinical study of the efficacies of ruxolitinib plus low-dose PTCY for acute GVHD prevention after haploidentical transplantation in malignant hematological diseases

原文传递
导出
摘要 Objective To investigate and verify a novel acute graft versus host disease (aGVHD) prevention protocol in the context of haploidentical hematopoietic stem cell transplantation (haplo-HSCT).Methods Patients who underwent haplo-HSCT in our center between January 2022 and December 2022 were included.
作者 LI Xiaoping 李小平(Dept Hematol,920th Hosp,Joint Logistics Support Force,Kunming 650000,China)
机构地区 Dept Hematol
出处 《China Medical Abstracts(Internal Medicine)》 2024年第3期188-189,共2页 中国医学文摘(内科学分册英文版)
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部